Viatris Inc And Kindeva Drug Delivery Announce FDA Tentative Approval Of The First Abbreviated New Drug Application Generic Version Of Symbicort (BudesonideFormoterol Fumarate Dihydrate) Inhalation Aerosol
News | March 8, 2021 Viatris Inc. And Kindeva Drug Delivery Announce FDA Tentative Approval Of The First Abbreviated New Drug Application Generic Version Of Symbicort® (Budesonide/Formoterol Fumarate Dihydrate) Inhalation Aerosol Source: Kindeva Drug Delivery Milestone reinforces Viatris' commitment to complex products and innovative solutions to help increase patient access PITTSBURGH and ST. PAUL, Minn., March 8, 2021 — Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that the U.S. Food and Drug Administration (FDA) granted tent...
Source: pharmaceuticalonline.com